Martin B. Edelshain
Plus aucun poste en cours
Profil
Martin B.
Edelshain joined Gen-Probe, Inc. in November 2003 as Vice President of Corporate Development and has been Senior Vice President-Corporate Strategy since May 2007.
He was a Business Consultant of Gen-Probe.
Mr. Edelshain was Director of International Strategy of Chugai Pharmaceutical Co. Ltd.
from 1995 to 2002.
He worked in the corporate finance of S.
G.
Warburg & Co. Ltd.
from 1970 to 1995.
Mr. Edelshain received a BA degree in Mechanical Sciences from Cambridge University.
Anciens postes connus de Martin B. Edelshain
| Sociétés | Poste | Fin |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | 01/01/2002 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Martin B. Edelshain
| University of Cambridge | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
